Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
OncoMyx to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Exicure to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Axovant to Participate in Upcoming October Conferences and Provide AXO-Lenti-PD Program Update the Morning of October 6th
-
Immunome (IMNM) IPO Opens 31% Higher
-
Beam Therapeutics to Participate in Chardan Virtual 4th Annual Genetic Medicines Conference
-
Beam Therapeutics to Participate in Chardan Virtual 4th Annual Genetic Medicines Conference
-
Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference
-
Immunome Inc. (IMNM) Prices 3.25M Share Upsized IPO at $12/Sh
-
Immunome Announces Pricing of Upsized Initial Public Offering
-
Solid Biosciences (SLDB) PT Raised to $12.50 at Chardan Capital Markets
-
LogicBio Therapeutics (LOGC) Prices 7M Share Public Offering of Common Stock at $6/Each
-
LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
-
LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
-
Mustang Bio to Participate in Chardan’s Virtual 4th Annual Genetic Medicines Conference 2020
-
Mustang Bio to Participate in Chardan’s Virtual 4th Annual Genetic Medicines Conference 2020
-
Editas Medicine to Participate in Upcoming Investor Conference
-
Editas Medicine to Participate in Upcoming Investor Conference
-
Diginex Lists and Begins Trading on Nasdaq
-
Replimune to Participate at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Silence Therapeutics to Participate in the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Sensorion Announces Attendance and Presentations at Upcoming Conferences
-
LogicBio Therapeutics (LOGC) Announces Proposed Common Offering
-
LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
-
Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conference
-
LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
-
Genenta to present preliminary Phase I/II clinical data on Temferon™ in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference
-
uniQure to Participate in Multiple Upcoming Industry Conferences in October
-
Translate Bio to Participate in Upcoming Investor Conferences
-
Taysha Gene Therapies Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
VBL Therapeutics to Present at the Chardan 4th Annual Genetic Medicines Conference
-
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
-
Ocugen to Participate in a Virtual Fireside Chat at the Chardan Genetic Medicines Conference
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
-
Tmunity to Present at Upcoming Investor Conferences
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
-
Aruvant to Present at Investor and Scientific Conferences in October
-
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
-
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
-
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Dicerna to Participate in the Chardan 4th Annual Genetic Medicines Conference
-
DTx Pharma to Present at the Chardan Virtual 4th Annual Genetic Medicines Event
-
Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic Medicines Conference 2020
-
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference
-
Moderna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
-
Arbutus to Participate in Virtual Fireside Chat at Chardan’s 4th Annual Genetic Medicines Conference
-
NeuBase Therapeutics to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th
-
Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference
-
Arbutus to Participate in Virtual Fireside Chat at Chardan’s 4th Annual Genetic Medicines Conference

